Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD-1).
Li, J., Kennedy, L.J., Walker, S.J., Wang, H., Li, J.J., Hong, Z., O'Connor, S.P., Ye, X.Y., Chen, S., Wu, S., Yoon, D.S., Nayeem, A., Camac, D.M., Ramamurthy, V., Morin, P.E., Sheriff, S., Wang, M., Harper, T.W., Golla, R., Seethala, R., Harrity, T., Ponticiello, R.P., Morgan, N.N., Taylor, J.R., Zebo, R., Maxwell, B., Moulin, F., Gordon, D.A., Robl, J.A.
ACS Med Chem Lett